Literature DB >> 18046026

Dengue and yellow fever--challenges for the development and use of vaccines.

Thomas P Monath1.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 18046026     DOI: 10.1056/NEJMp0707161

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  22 in total

1.  A case of yellow fever vaccine-associated viscerotropic disease in Ecuador.

Authors:  Richard W Douce; Diana Freire; Betzabe Tello; Gavino A Vásquez
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

2.  Temperature-dependent production of pseudoinfectious dengue reporter virus particles by complementation.

Authors:  Camilo Ansarah-Sobrinho; Steevenson Nelson; Christiane A Jost; Stephen S Whitehead; Theodore C Pierson
Journal:  Virology       Date:  2008-09-17       Impact factor: 3.616

3.  Inferring the serotype associated with dengue virus infections on the basis of pre- and postinfection neutralizing antibody titers.

Authors:  Willem G van Panhuis; Robert V Gibbons; Timothy P Endy; Alan L Rothman; Anon Srikiatkhachorn; Ananda Nisalak; Donald S Burke; Derek A T Cummings
Journal:  J Infect Dis       Date:  2010-10-01       Impact factor: 5.226

4.  Update on dengue: epidemiology, virus evolution, antiviral drugs, and vaccine development.

Authors:  Annelies Wilder-Smith; Eng-Eong Ooi; Subhash G Vasudevan; Duane J Gubler
Journal:  Curr Infect Dis Rep       Date:  2010-05       Impact factor: 3.725

5.  Targeted delivery of small interfering RNA to human dendritic cells to suppress dengue virus infection and associated proinflammatory cytokine production.

Authors:  Sandesh Subramanya; Sang-Soo Kim; Sojan Abraham; Jiahong Yao; Mukesh Kumar; Priti Kumar; Viraga Haridas; Sang-Kyung Lee; Leonard D Shultz; Dale Greiner; Manjunath N; Premlata Shankar
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

6.  Effects of inbreeding and genetic modification on Aedes aegypti larval competition and adult energy reserves.

Authors:  Constantianus Jm Koenraadt; Matthias Kormaksson; Laura C Harrington
Journal:  Parasit Vectors       Date:  2010-10-06       Impact factor: 3.876

7.  Phase 1 trial of the dengue virus type 4 vaccine candidate rDEN4{Delta}30-4995 in healthy adult volunteers.

Authors:  Peter F Wright; Anna P Durbin; Stephen S Whitehead; Mine R Ikizler; Susan Henderson; Joseph E Blaney; Bhavin Thumar; Sharon Ankrah; Michael T Rock; Brett A McKinney; Brian R Murphy; Alexander C Schmidt
Journal:  Am J Trop Med Hyg       Date:  2009-11       Impact factor: 2.345

Review 8.  Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development.

Authors:  Theodore C Pierson; Daved H Fremont; Richard J Kuhn; Michael S Diamond
Journal:  Cell Host Microbe       Date:  2008-09-11       Impact factor: 21.023

9.  Skeeter Buster: a stochastic, spatially explicit modeling tool for studying Aedes aegypti population replacement and population suppression strategies.

Authors:  Krisztian Magori; Mathieu Legros; Molly E Puente; Dana A Focks; Thomas W Scott; Alun L Lloyd; Fred Gould
Journal:  PLoS Negl Trop Dis       Date:  2009-09-01

10.  Humoral immune responses of dengue fever patients using epitope-specific serotype-2 virus-like particle antigens.

Authors:  Wayne D Crill; Holly R Hughes; Mark J Delorey; Gwong-Jen J Chang
Journal:  PLoS One       Date:  2009-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.